PET/CT in Gynecologic Cancer: Present Applications and Future Prospects-A Clinician's Perspective

Amnon Amit; Julian Schink; Ari Reiss; Lior Lowenstein

doi:10.1016/j.cpet.2010.07.001

PET/CT in Gynecologic Cancer: Present Applications and Future Prospects-A Clinician's Perspective

PET Clin. 2010 Oct;5(4):391-405. doi: 10.1016/j.cpet.2010.07.001. Epub 2010 Aug 4.

Authors

Amnon Amit¹, Julian Schink², Ari Reiss³, Lior Lowenstein³

Affiliations

¹ Division of Gyneco-oncology, Rambam Health Care Campus, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 9602, Israel. Electronic address: a_amit@rambam.health.gov.il.
² John I. Brewer Trophoblastic Disease Center, Northwestern University Feinberg School of Medicine, 250 East Superior Street, Suite 5-2168, Chicago, IL, USA.
³ Division of Gyneco-oncology, Rambam Health Care Campus, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 9602, Israel.

PMID: 27157968
DOI: 10.1016/j.cpet.2010.07.001

Abstract

This article briefly reviews the epidemiology, diagnosis, and treatment of the common gynecologic malignancies, with an emphasis on the shortcomings of current clinical practice. The persistent need to achieve early diagnosis, adjust proper treatment, enhance surveillance, and improve the outcome of these patients has led to the development of new diagnostic modalities. Novel tools such as 18F-fluorodeoxyglucose PET/CT should aim at enhancing the clinician's ability to make critical decisions in treating difficult scenarios.

Keywords: (18)F-Fluorodeoxyglucose PET; Best practice; Cross-sectional imaging; Gynecologic cancer.

Publication types

Review